8-K 1 c90026e8vk.htm FORM 8-K e8vk
Table of Contents

UNITED STATES
SECURITIES AND EXCHANGE COMMISSION

Washington, D.C. 20549

FORM 8-K

Current Report Pursuant to Section 13 or 15(d) of
the Securities Exchange Act of 1934

Date of Report (Date of earliest event reported): November 18, 2004

ROCHESTER MEDICAL CORPORATION

(Exact name of registrant as specified in its charter)
         
Minnesota   0-18933   41-1613227
  		 
  		 
 
(State or other jurisdiction
of incorporation) 		  (Commission file number)   (I.R.S. Employer
Identification No.)
     
One Rochester Medical Drive, Stewartville, MN 55976
 
(Address of principal executive offices)
 
Registrant’s telephone number, including area code: (507) 533-9600
 
 
Not Applicable
 
(Former name or former address, if changed since last report)

Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions (see General Instruction A.2. below):

     
o   Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425)
     
o   Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12)
     
o   Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b))
     
o   Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c))

 

TABLE OF CONTENTS

Item 1.01. Entry into a Material Definitive Agreement.
Item 9.01. Financial Statements and Exhibits.
SIGNATURE
EXHIBIT INDEX
Fiscal 2005 Executive Compensation Plan

Table of Contents

Item 1.01. Entry into a Material Definitive Agreement.

     On November 18, 2004, the Compensation Committee of the Board of Directors of Rochester Medical Corporation (the “Company”) approved a cash bonus management incentive plan for the fiscal year ending September 30, 2005 (the “Plan”). The Company’s management personnel will be entitled to earn bonus incentive compensation under the Plan based upon the Company’s financial performance in fiscal 2005, including the Company’s net sales and operating income. A copy of the Plan is filed as Exhibit 10.1 to, and incorporated by reference in, this report.

Item 9.01. Financial Statements and Exhibits.

     (c)   Exhibits.

     10.1       Fiscal 2005 Executive Compensation Plan

 

Table of Contents

SIGNATURE

     Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned, hereunto duly authorized.

Date: November 24, 2004
         
  ROCHESTER MEDICAL CORPORATION
 		  
  By:   /s/ David A. Jonas    
    David A. Jonas   
    Chief Financial Officer   

 

Table of Contents

         

EXHIBIT INDEX

       
Exhibit No.
   Description
10.1
  Fiscal 2005 Executive Compensation Plan